1. Accueil
  2. Michel Toungouz Névessignsky
  3. Michel Toungouz Névessignsky

Onglets principaux

Rechercher
Limit to
Exporter 2 resultats:
Filtres: Auteur is Michel Toungouz Nevessignsky
2020
Correction to: A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of valescent plasma to the standard of care in patients hospitalized with COVID- nCoV (DAWn-Plasma) trial., Devos, Timothy , Trials, 2020 Dec 14, Volume 21, Issue 1, (2020)
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the DAWn-Plasma trial., Devos, Timothy, Geukens Tatjana, Schauwvlieghe Alexander, Ariën Kevin K., Barbezange Cyril, Cleeren Myriam, Compernolle Veerle, Dauby Nicolas, Desmecht Daniel, Grimaldi David, et al. , Trials, 2020 Nov 27, Volume 21, Issue 1, (2020)

QR code

QR code for this page URL